Evaluation of large language models in female malignancy Q&A
Open Access
- 12 September 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (37) , e44418
Abstract
The future of artificial intelligence specialist doctors depends on foundational large language models (LLMs). However, there is currently a lack of evaluation studies on their Q&A capabilities in female malignancy. This cross-sectional study created a benchmark dataset consisting of 205 female malignancy Q&A to evaluate and compare the performance of 7 popular LLMs, with 3 human oncologists serving as a comparison. Only OpenAI o1, DeepSeek-R1, and Llama-3.1-405B achieved both accuracy and consistency rates exceeding 80%. Among these, Llama-3.1-405B demonstrated significantly higher accuracy than OpenAI o1 ( P = .002) and potentially higher than DeepSeek-R1 ( P = .059), with significantly lower latency ( P < .001). After removing token limits, both OpenAI o1 and DeepSeek-R1 exhibited strong reasoning abilities, achieving accuracy rates of 98.5% and 95.6%, respectively, with no significant difference from Llama-3.1-405B ( P > .05). The agreement between the models was fair, with an agreement rate of 0.318. Error analysis revealed that the highest error rates were associated with questions involving flexible medical scenarios and complex medical terminology. In female malignancy Q&A tasks, Llama-3.1-405B serves as a strong baseline model, while OpenAI o1 and DeepSeek-R1 show promise in inference, especially when token limitations are removed. However, their reasoning processes lack full consistency, likely due to differences in architectures and training methods. LLMs continue to face challenges in real-world medical scenarios and with complex medical terminology, highlighting the need for ongoing updates and the integration of clinical data to refine these models and improve their ability to address specialized medical needs.Keywords
Funding Information
- Project of National Clinical Research Base of Traditional Chinese Medicine in Jiangsu Province, China (JD2023SZ17)
This publication has 10 references indexed in Scilit:
- Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancerInternational Journal of Cancer, 2025
- Global, regional, and national burden of breast, cervical, uterine, and ovarian cancer and their risk factors among women from 1990 to 2021, and projections to 2050: findings from the global burden of disease study 2021BMC Cancer, 2025
- Text understanding in GPT-4 versus humansRoyal Society Open Science, 2025
- Progressive role of artificial intelligence in treatment decision-making in the field of medical oncologyFrontiers in Medicine, 2025
- China’s cheap, open AI model DeepSeek thrills scientistsNature, 2025
- Correction: Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the global burden of Disease Study 2021Biomarker Research, 2025
- OpenAI o1-Preview vs. ChatGPT in Healthcare: A New Frontier in Medical AI ReasoningCureus, 2024
- Global burden and trends in pre- and post-menopausal gynecological cancer from 1990 to 2019, with projections to 2040: a cross-sectional studyInternational Journal of Surgery, 2024
- Llama 3 Challenges Proprietary State-of-the-Art Large Language Models in Radiology Board–style Examination QuestionsRadiology, 2024
- Artificial Intelligence in Healthcare: Past, Present and FutureThe Anatolian Journal of Cardiology, 2019